<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">1</item><item key="sample_count">8</item><item key="tags"><item>acute lymphoblastic leukemia</item><item>cancer</item><item>cell</item><item>goblet cell</item><item>hematologic cancer</item><item>leukemia</item><item>line</item><item>lymphoblastic leukemia</item></item><item key="slug">preclinical-analysis-of-the-gamma-secretase-inhibi</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33562</item><item key="species">human</item><item key="id">4302</item><item key="name">Preclinical analysis of the gamma secretase inhibitor PF-030840214 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia</item></item><item><item key="factor_count">1</item><item key="sample_count">14</item><item key="tags"><item>cancer</item><item>colorectal cancer</item><item>genome</item><item>line</item></item><item key="slug">prediction-of-response-to-bevacizumab</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19862</item><item key="species">human</item><item key="id">3551</item><item key="name">Prediction of response to bevacizumab</item></item><item><item key="factor_count">1</item><item key="sample_count">40</item><item key="tags"><item>cancer</item><item>colorectal cancer</item><item>genome</item><item>line</item></item><item key="slug">prediction-of-response-to-folfox</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19860</item><item key="species">human</item><item key="id">3550</item><item key="name">Prediction of response to FOLFOX</item></item><item><item key="factor_count">2</item><item key="sample_count">14</item><item key="tags"><item>cancer</item><item>cell</item><item>endometrial cancer</item><item>line</item></item><item key="slug">progesterone-inhibits-epithelial-to-mesenchymal-3</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29437</item><item key="species">human</item><item key="id">4100</item><item key="name">Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer</item></item><item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>cancer</item><item>cell</item><item>disease</item><item>endometrial cancer</item><item>genome</item><item>line</item><item>mesenchymal cell</item><item>vimentin</item></item><item key="slug">progesterone-inhibits-epithelial-to-mesenchymal-tr</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29435</item><item key="species">human</item><item key="id">4098</item><item key="name">Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer: cell line data</item></item><item><item key="factor_count">1</item><item key="sample_count">8</item><item key="tags"><item>adipocyte</item><item>cell</item><item>disease</item><item>line</item><item>lipid</item><item>pluripotent stem cell</item><item>stem cell</item></item><item key="slug">programming-human-pluripotent-stem-cells-into-adip</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-30038</item><item key="species">human</item><item key="id">4139</item><item key="name">Programming human pluripotent stem cells into adipocytes [Affymetrix]</item></item><item><item key="factor_count">1</item><item key="sample_count">11</item><item key="tags"><item>cell</item><item>line</item><item>sarcoma</item></item><item key="slug">re-activation-of-ews-fli1-suppressed-foxo1-express</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-37409</item><item key="species">human</item><item key="id">2373</item><item key="name">Re-activation of EWS-FLI1 suppressed FOXO1 expression as a novel therapeutic strategy for Ewing&#180;s sarcoma</item></item><item><item key="factor_count">2</item><item key="sample_count">81</item><item key="tags"><item>line</item><item>skin</item></item><item key="slug">re-analysis-by-microarray-using-cdna-target-of-sam</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-41663</item><item key="species">human</item><item key="id">4598</item><item key="name">Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial</item></item><item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>axis</item><item>cancer</item><item>cell</item><item>glutamine</item><item>line</item><item>pancreatic cancer</item><item>prostate</item><item>prostate cancer</item><item>serum</item></item><item key="slug">regulation-of-autophagy-by-vegf-c-axis-in-cancer</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-36085</item><item key="species">human</item><item key="id">4431</item><item key="name">Regulation of Autophagy by VEGF-C axis in cancer</item></item><item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>cancer</item><item>cell</item><item>head</item><item>head and neck cancer</item><item>line</item><item>neck</item><item>neck cancer</item><item>point</item></item><item key="slug">regulation-of-hb-egf-by-mir-212-and-acquired-cetux</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-21483</item><item key="species">human</item><item key="id">3640</item><item key="name">Regulation of HB-EGF by miR-212 and acquired cetuximab-resistance in head and neck cancer</item></item></data></biogps>
